Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 2
1994 5
1995 7
1996 10
1997 3
1998 8
1999 2
2000 4
2001 4
2002 5
2003 7
2004 10
2005 5
2006 3
2007 13
2008 15
2009 17
2010 10
2011 13
2012 13
2013 12
2014 16
2015 21
2016 27
2017 53
2018 67
2019 49
2020 39
2021 35
2022 27
2023 32
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

490 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023.
Cohen Tervaert JW, Martinez-Lavin M, Jara LJ, Halpert G, Watad A, Amital H, Shoenfeld Y. Cohen Tervaert JW, et al. Among authors: amital h. Autoimmun Rev. 2023 May;22(5):103287. doi: 10.1016/j.autrev.2023.103287. Epub 2023 Feb 3. Autoimmun Rev. 2023. PMID: 36738954 Free article. Review.
Fibromyalgia position paper.
Sarzi-Puttini P, Giorgi V, Atzeni F, Gorla R, Kosek E, Choy EH, Bazzichi L, Häuser W, Ablin JN, Aloush V, Buskila D, Amital H, Da Silva JAP, Perrot S, Morlion B, Polati E, Schweiger V, Coaccioli S, Varrassi G, Di Franco M, Torta R, Øien Forseth KM, Mannerkorpi K, Salaffi F, Di Carlo M, Cassisi G, Batticciotto A. Sarzi-Puttini P, et al. Among authors: amital h. Clin Exp Rheumatol. 2021 May-Jun;39 Suppl 130(3):186-193. doi: 10.55563/clinexprheumatol/i19pig. Epub 2021 May 13. Clin Exp Rheumatol. 2021. PMID: 34001303 Free article. Review.
Covid-19 and autoimmunity.
Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, Alijotas-Reig J, Zinserling V, Semenova N, Amital H, Shoenfeld Y. Ehrenfeld M, et al. Among authors: amital h. Autoimmun Rev. 2020 Aug;19(8):102597. doi: 10.1016/j.autrev.2020.102597. Epub 2020 Jun 11. Autoimmun Rev. 2020. PMID: 32535093 Free PMC article. Review. No abstract available.
Reply.
Ben-Shabat N, Shabat A, Watad A, Kridin K, Bragazzi NL, McGonagle D, Comaneshter D, Cohen AD, Amital H. Ben-Shabat N, et al. Among authors: amital h. Arthritis Care Res (Hoboken). 2022 Dec;74(12):2121-2122. doi: 10.1002/acr.24771. Epub 2022 Aug 23. Arthritis Care Res (Hoboken). 2022. PMID: 34437772 No abstract available.
T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17‒Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune Diseases.
Bridgewood C, Wittmann M, Macleod T, Watad A, Newton D, Bhan K, Amital H, Damiani G, Giryes S, Bragazzi NL, McGonagle D. Bridgewood C, et al. Among authors: amital h. J Invest Dermatol. 2022 Oct;142(10):2660-2667. doi: 10.1016/j.jid.2022.03.013. Epub 2022 Apr 6. J Invest Dermatol. 2022. PMID: 35395222 Free article.
Efficacy and Safety of ABBV-3373, a Novel Anti-Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody-Drug Conjugate, in Adults with Moderate-to-Severe Rheumatoid Arthritis Despite Methotrexate Therapy: A Randomized, Double-Blind, Active-Controlled Proof-of-Concept Phase IIa Trial.
Buttgereit F, Aelion J, Rojkovich B, Zubrzycka-Sienkiewicz A, Chen S, Yang Y, Arikan D, D'Cunha R, Pang Y, Kupper H, Radstake T, Amital H. Buttgereit F, et al. Among authors: amital h. Arthritis Rheumatol. 2023 Jun;75(6):879-889. doi: 10.1002/art.42415. Epub 2023 Apr 2. Arthritis Rheumatol. 2023. PMID: 36512671 Clinical Trial.
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
Fleischmann R, Mysler E, Hall S, Kivitz AJ, Moots RJ, Luo Z, DeMasi R, Soma K, Zhang R, Takiya L, Tatulych S, Mojcik C, Krishnaswami S, Menon S, Smolen JS; ORAL Strategy investigators. Fleischmann R, et al. Lancet. 2017 Jul 29;390(10093):457-468. doi: 10.1016/S0140-6736(17)31618-5. Epub 2017 Jun 16. Lancet. 2017. PMID: 28629665 Clinical Trial.
Fibromyalgia and Its Consequent Disability.
Ben-Yosef M, Tanai G, Buskila D, Amital D, Amital H. Ben-Yosef M, et al. Among authors: amital h. Isr Med Assoc J. 2020 Jul;22(7):446-450. Isr Med Assoc J. 2020. PMID: 33236571 Free article. Review.
490 results